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Regnase-1 and Roquin are RNA binding proteins
essential for degradation of inflammation-related
mRNAs and maintenance of immune homeostasis.
However, their mechanistic relationship has yet to
be clarified. Here, we show that, although Regnase-1
and Roquin regulate an overlapping set of mRNAs
via a common stem-loop structure, they function
in distinct subcellular locations: ribosome/endo-
plasmic reticulum and processing-body/stress gran-
ules, respectively. Moreover, Regnase-1 specifically
cleaves and degrades translationally active mRNAs
and requires the helicase activity of UPF1, similar to
the decay mechanisms of nonsense mRNAs. In
contrast, Roquin controls translationally inactive
mRNAs, independent of UPF1. Defects in both Reg-
nase-1 and Roquin lead to large increases in their
target mRNAs, although Regnase-1 tends to control
the early phase of inflammation when mRNAs are
more actively translated. Our findings reveal that dif-
ferential regulation of mRNAs by Regnase-1 and
Roquin depends on their translation status and en-
ables elaborate control of inflammation.
INTRODUCTION
Inflammation is mediated by proinflammatory cytokines such as
tumor necrosis factor (TNF) and interleukin 6 (IL-6). Expression of1058 Cell 161, 1058–1073, May 21, 2015 ª2015 Elsevier Inc.cytokines is rapidly induced in response to infection by patho-
gens via Toll-like receptors (TLRs) in innate immune cells (Cho-
vatiya and Medzhitov, 2014; Moresco et al., 2011; Takeuchi
and Akira, 2010). Whereas cytokine mRNA levels are controlled
at both transcriptional and post-transcriptional levels, post-tran-
scriptional dampening of protein expression in particular can
resolve inflammation and prevent unintended tissue damage
(Anderson, 2010; Kafasla et al., 2014). Eukaryotic mRNAs are
in dynamic equilibrium between different subcellular locations:
actively translated mRNAs can be found in polysomes, mRNAs
stalled in translation initiation can accumulate in stress granules
(SGs), and mRNAs targeted for degradation or translation
repression can accumulate in processing bodies (PBs). Further,
mRNA-protein (mRNP) complexes dynamically move between
polysomes, SGs, and PBs (Anderson and Kedersha, 2009; Bala-
gopal and Parker, 2009).
Many immune-related mRNAs have short half-lives because
of conserved cis-elements, including AU-rich elements (AREs)
and stem-loop (SL) structures in their 30 UTRs (Anderson,
2010; Kafasla et al., 2014). ARE binding proteins are involved
in controlling the stability of such mRNAs. In addition, SLs pre-
sent in mRNAs, including ICOS, OX40, and TNF, are destabi-
lized by Roquin-1 and -2 (Leppek et al., 2013). These proteins
harbor an RNA binding ROQ domain whose loss-of-function
mutation (M199R) in mice (San) leads to the development of
autoimmune disease characterized by an increase in follicular
helper T cells (Linterman et al., 2009; Vinuesa et al., 2005; Yu
et al., 2007). ARE- and Roquin-mediated mRNA decay takes
place in PBs or SGs where a CCR4-CAF1-NOT deadenylase
complex is recruited (Anderson, 2010; Athanasopoulos et al.,
2010).







Figure 1. Identification of Reg1 Target mRNAs
(A) SHAPE analysis of in vitro synthesized Il6 30 UTR (84–103) RNA.
(B and C) Schematic representation of Il6 30 UTR (84–103) (B) and Il6 30 UTR and antisense morpholinos (C).
(legend continued on next page)
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In contrast, another set of mRNA decay pathways targets
mRNAs undergoing translation. In the nonsense-mediated
decay (NMD), premature translation termination at more than
20–25 bases 50 of the exon junction complex (EJC) promotes
the recruitment of an SMG1-UPF1-eRF1-eRF3 (SURF) complex
(Kervestin and Jacobson, 2012; Popp and Maquat, 2013;
Schweingruber et al., 2013). The SURF complex then interacts
with the UPF2-UPF3-EJC complex, leading to recruitment of
the endonucleases SMG6, SMG5, and SMG7, which mediate
deadenylation for further degradation. In addition, active transla-
tion and UPF1 are required for some normal mRNA decay path-
ways, including staufen1-mediated mRNA decay (SMD) and
replication-dependent histone mRNA decay (Kaygun and Mar-
zluff, 2005; Kim et al., 2005).
We identified Regnase-1 (Reg1; also known as Zc3h12a and
Mcpip1) as an RNase critical for preventing a severe autoim-
mune inflammatory disease in mice by destabilizing inflamma-
tion-related mRNAs (Iwasaki et al., 2011; Matsushita et al.,
2009). Reg1 harbors a PIN-like RNase domain and controls a
set of genes including Il6 and Reg1 itself, but not Nfkbia, in mac-
rophages following stimulation with TLR ligands such as lipo-
polysaccharide (LPS) and IL-1b, which activate shared signaling
pathways. Reg1 is also essential for suppressing aberrant acti-
vation of T cells by targeting genes such as Icos, c-Rel, and
Ox40 for degradation (Uehata et al., 2013).
In this study, we aim to uncover how Reg1 recognizes and de-
grades its target mRNAs, andwe show that Reg1 interacts with a
set of SL-containingmRNAs that overlaps with those targeted by
Roquin. In contrast to Roquin, Reg1 co-localizes with ribosomes,
but not with PBs and SGs. Reg1 destabilizes translationally
activemRNAs and requires UPF1. The apparent cooperation be-
tween Reg1 and Roquin is confirmed by the upregulation of their
mutual target mRNAs under mutation of both Reg1 and Roquin,
although Reg1 and Roquin tend to control the early and late
phases of inflammation, respectively. Thus, a common set of
SL-containing mRNAs is recognized by distinct proteins in
different stages of mRNA metabolism for fine tuning of immune
responses.
RESULTS
SL Structure Required for Reg1-RNA Association
We previously showed that a potential SL sequence in the Il6 30
UTR (84–102) is recognized by Reg1 for degradation (Matsushita(D) HeLa cells were transfected with the Il6 30 UTR reporter, antisensemorpholinos
values.
(E) Ctrl- and Il6-SL-MO were delivered into WT BMMs followed by stimulation wit
qPCR and ELISA, respectively.
(F) WT BMMs delivered with antisense morpholinos were i.p. transfused into Il6–/
BW). Cytokine levels in sera were measured by ELISA 24 hr after transfusion.
(G) Schematic representation of lN-BoxB tethering system.
(H) Tef-off 293 cells were transfected with pTRE-Il6CDS-5XBoxB and indicated
levels were determined by Northern blot analysis.
(I) Immunoblot analysis of Reg1 in HeLa cells transfected with indicated express
(J) Correlation of ppm between control IP samples (x axis) and Reg1 IP sample
determined by RIP-seq.
(K) Luciferase activity of HeLa cells transfected with reporter plasmids expressin
Unless otherwise indicated, data are mean ± SD (n = 3). See also Figure S1 and
1060 Cell 161, 1058–1073, May 21, 2015 ª2015 Elsevier Inc.et al., 2009). To determine the secondary structure of the Il6 30
UTR target sequence, we performed selective 20-hydroxyl acyl-
ation analyzed by primer extension (SHAPE) analysis. The
SHAPE results were consistent with the computational predic-
tion of a simple SL structure with bulge (Figures 1A and 1B).
We then examined whether the SL is critical for the control of
Il6 expression by Reg1 by using an antisense morpholino that
can interfere with SL formation in Il6 30 UTR (Il6-SL-MO) (Fig-
ure 1C). A luciferase assay expressing the reporter construct
with the Il6 30 UTR, the morpholinos, and Reg1 revealed that
the suppression of the luciferase activity observed in control
(Ctrl) morpholino transfected cells was cancelled by the Il6-SL-
MO (Figure 1D). Following introduction of the Il6-SL-MO to
mouse bone marrow macrophages (BMMs), LPS-induced
expression of mRNA and protein for IL-6, but not TNF, were
significantly elevated compared with control cells (Figure 1E).
We further supplemented Il6–/– mice with wild-type (WT) BMM
treated with the Il6-SL-MO. LPS-induced production of IL-6,
but not TNF, in the sera was elevated in mice supplemented
with Il6-SL-MO-treated BMM, indicating that the SL in the Il6 30
UTR is important for the regulation of IL-6 production in vivo
(Figure 1F).
To investigate whether the conserved SL is required for pro-
cessing by Reg1, which harbors endonuclease activity as shown
by the digestion of circular RNA in vitro (Figures S1A and S1B),
we synthesized Il6 30 UTR RNAs with and without the SL (Fig-
ure S1C). Reg1 degraded RNAs harboring the SL, but not
without the SL (Figure S1C), suggesting that the SL is required
for RNase-mediated digestion or RNA binding. To distinguish
between these two possibilities, we artificially tethered Reg1 to
Il6 coding and luciferasemRNAs using the lN-BoxB system (Fig-
ure 1G). Interestingly, a lN-Reg1, but not WT Reg1, destabilized
the Il6 coding sequence in the presence of 5XBoxB in the Tet-off
system (Figures 1H and 1I). This was further confirmed by a lucif-
erase reporter assay expressing the luciferase construct with
5XBoxB in the 30 UTR and lN-Reg1 (Figure S1D), indicating
that the SL is required for the recruitment of target mRNAs by
Reg1 but is dispensable for their degradation.
To check the possibility of Reg1-mediated control of miRNA
generation (Suzuki et al., 2011), we prepared small RNAs from
Reg1–/– mouse embryonic fibroblasts (MEFs). qPCR analysis re-
vealed that the levels of miRNAs previously reported to be regu-
lated by Reg1, as well as a set of LPS-inducible miRNAs
including miR-155 and miR-146a, did not increase in the, and Reg1 expression plasmids. The luciferase activities are shown as relative
h LPS. Cytokine mRNA (top) and protein (bottom) levels were analyzed by RT-
– mice (6 weeks old, n = 4). The mice were i.p. injected with LPS (0.5 mg/kg of
expression plasmids. Total RNAs were prepared after Dox treatment, and Il6
ion plasmids.
s (y axis). mRNAs associated with Reg1 in IL-1b-stimulated HeLa cells were
g 30 UTR of indicated genes and Reg1 expression plasmids.








Figure 2. Identification of the Consensus Sequences of the Reg1 Target mRNAs and Their Overlap with Roquin
(A and B) GSEA of overlap between Reg1 and Roquin target genes (RIP-seq based). ES plots are shownwith genes ranked according to their Roquin (A) and Reg1
(B) RIP-seq p values. The right part shows the histogram for the max ES scores.
(legend continued on next page)
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absence of Reg1 (Figure S1E), indicating that Reg1 is dispens-
able for the control of these miRNAs.
Identification of mRNAs Associating with Reg1
To comprehensively identify mRNAs associated with Reg1, we
performed RNA-immunoprecipitation (IP) sequencing (RIP-seq)
analysis. We expressed Flag-Reg1 lacking RNase activity
(D141N), which was predicted to retain RNA binding activity (Fig-
ure S1F), in HeLa cells. We found that IL6 and Reg1 (ZC3H12A)
were highly enriched by IP with Reg1 compared with control IP,
both in unstimulated and IL-1b-stimulated cells (Figure 1J and
Table S1), indicating that IP with Reg1 properly co-precipitated
its target mRNAs. A total of 68 mRNAs were significantly en-
riched either in unstimulated or IL-1b-stimulated cells (p values <
103) compared with control cells (Table S1). Gene ontology
annotations enriched for the 68 Reg1-interacting mRNAs were
often involved in inflammation (Table S2).
We then investigated whether the Reg1-binding mRNAs were
targeted by Reg1 for degradation. We constructed luciferase
reporter genes with 30 UTRs from a set of enriched genes,
including Nfkbiz, Nfkbid, Ptgs2, Mafk, Id1, Cxcl1, Cxcl2, and
Cxcl3. Overexpression of Reg1 suppressed the luciferase
activity in an RNase-activity-dependent manner (Figure 1K).
Consistent with a previous report (Iwasaki et al., 2011), overex-
pression of Reg1 suppressed Reg1 30 UTR-containing nucleo-
tides 1–210, but not in the case where nucleotides 1–200,
which contain the SL, were absent. Collectively, Reg1-bound
mRNAs obtained by RIP-Seq are indeed targeted by Reg1 for
degradation.
The Reg1 Target Consensus Motif Overlaps with that of
Roquin
Roquin-1 was also reported to associate with SL-containing
mRNAs such as Tnf, Icos, Nfkbid, and Nfkbiz in RAW264.7 cells
(Leppek et al., 2013). Indeed, overexpression of Roquin sup-
pressed the luciferase activity in the presence of the 30 UTR of
Nfkbiz, Nfkbid, and Ptgs2 (Figure S1G), suggesting an overlap
between Reg1 and Roquin target mRNAs.
We therefore next examined Roquin-interacting mRNAs glob-
ally in HeLa cells by RIP-seq analysis. A total of 52 high-confi-
dence mRNAs were enriched by IP with Flag-Roquin either in
unstimulated or IL-1b-stimulated cells (p values < 0.01) (Table
S3). Gene Set Enrichment Analysis (GSEA) showed that
68 Reg1 targets (p % 1.0 3 103) were significantly biased
toward high enrichment scores (ES) in the Roquin RIP-seq
data (p < 1 3 104; Figure 2A). We found a similar significant
enrichment of Reg1 targets among mRNAs enriched in the(C, G, J, and K) Luciferase activity of HeLa cells transfected with indicated repor
(D) Phosphorimages of NuPAGE gels that resolved 50-[32P]-labeled RNA-Flag-Re
(E) Proportion of Reg1 binding sites obtained by the intersection of two biologica
(F) Schematic representation of TM2D3 (95–120).
(H) SL enrichment in Reg1-bound CLIP tags in 30 UTRs compared to 1,000 individu
to the enrichment.
(I) Description of significantly enriched Reg1-bound SLs harboring a hairpin of t
Representation of SL sequence as position weight matrix (PWM) logos. Logos
nucleotide entropy.
See also Figures S2 and S3 and Table S3 and S4.
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test (p < 2.23 1016). Reciprocally, the set of 52 high-confidence
Roquin targets (p % 0.01) showed a significant overlap with
mRNAs enriched in the Reg1 RIP-seq data (p < 1 3 104; Fig-
ure 2B). These 52 Roquin targets shared 10 mRNAs with the
68 Reg1 targets (p = 2.69 3 1015). These results demonstrate
that the Reg1 and Roquin target mRNAs overlap significantly.
Among newly identified Reg1-associatedmRNAs, we focused
on two mRNAs, Nfkbiz and Ptgs2. By testing luciferase con-
structs with truncated Nfkbiz 30 UTRs (Figure S2A), we found
that Nfkbiz (100–150), which is evolutionally conserved and pre-
dicted to contain two SLs (Figures S2B and S2C), is required for
Reg1-mediated suppression. Addition of either one of these SL
to the b-globin 30 UTR conferred responsiveness to Reg1 (Fig-
ure S2D). Similarly, we found that Ptgs2 (1000–1300) was
required for the regulation by Reg1 (Figure S2E). Mouse Ptgs2
(1211–1228) was predicted and shown to form a conserved SL
(Figures S2F–S2H), and this sequence alone was sufficient for
Reg1 to suppress luciferase activity (Figure S2I). In addition,
we found that a luciferase construct with the constitutive decay
element (CDE) present in Tnf mRNA, which was identified as a
Roquin target SL (Leppek et al., 2013), and SL alone (TNF-
CDE37) was suppressed by Reg1 (Figure 2C and S2J).
Next, we investigated target structures present in Reg1 bind-
ing mRNAs globally by high-throughput sequencing of RNA
isolated by crosslinking immunoprecipitation (HITS-CLIP) in
HEK293 cells (chosen because of their wide usage in CLIP anal-
ysis) with stable, inducible expression of FLAG-tagged WT Reg1
(Figure 2D). UV-crosslinked RNAs co-precipitated with Flag-
Reg1 were recovered and sequenced. By analyzing sequence
data of two biological replicate libraries, we identified 9,107
and 10,448 putative Reg1 binding sites in two biological dupli-
cate libraries, respectively (Table S4). The two libraries inter-
sected on a group level with at least one overlapping nucleotide;
we thereby obtained 1,143 Reg1 binding sites. As expected,
many sites were located in 30 UTRs, although some fractions
were mapped to coding regions and other regions (Figure 2E).
Although immune-related mRNAs were not frequently observed
in HEK293 cells because of their poor expression, we identified
Reg1 target sites in genes such as TM2D3, which was identified
by RIP-seq analysis. The obtained sequences from them were
predicted to form SLs (Figure 2F) and were suppressed by
Reg1 (Figure 2G). When the Reg1 binding sequences were glob-
ally folded using RNAfold, SL structures with 3–7 nucleotide
stems and 3 nucleotide loops were significantly enriched
compared with 1,000 individual permutations (p < 0.001) (Fig-
ure 2H). Next, we investigated the sequence motifs enriched inter, Reg1, and Roquin expression plasmids. Data are mean ± SD (n = 3).
g1 IP. Lower panels show immunoblots for Reg1.
l HITS-CLIP replicates.
al sequence permutations. The bar color represents the p value corresponding
hree nucleotides with varying stem length (three, five, or seven nucleotides).







(legend on next page)
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the Reg1 binding SLs harboring a hairpin of 3 nucleotides
with varying stem lengths (3, 5, or 7 nucleotides). Interestingly,
the UAU sequence was enriched in the hairpin sequences
(Figure 2I).
Next, we examined the requirement of the SL structure and the
specific hairpin loop sequence for Reg1-mediated target mRNA
suppression. Using two validated SLs, TNF-CDE and another
artificial SL with an UAU loop (Figures S3A–S3C), we first
analyzed the importance of SL structures. Disruption of the SL
structures abrogated Reg1-mediated suppression, and restora-
tion of the SL structure by mutating both sides of the stem re-
sulted in rescue of Reg1-mediated suppression (Figures S3D
and S3E). We then generated a set of luciferase constructs
harboring SLs with different loop sequences. In addition to SLs
with UAU, UGU loop sequences were significantly inhibited by
Reg1 overexpression (Figure 2J), indicating that SL sequences
with either A or G at the second residue in the hairpin loop can
be suppressed by Reg1. In contrast, ACA, AAA, or UCU SLs
were not suppressed by Reg1 expression, suggesting that a
pyrimidine-purine-pyrimidine (Py-Pu-Py) sequence should be
present in the loop.
Furthermore, IP with Reg1 co-precipitated reporter mRNA
with a SL structure, whereas reporters whose SL was disrupted
no longer co-precipitated with Reg1 (Figures S3F and S3G), indi-
cating that the SL structure is required for Reg1 binding in cells.
Additionally, alteration in the loop sequence abrogated its bind-
ing with Reg1 (Figure S3H).
Reciprocally, Roquin overexpression suppressed the lucif-
erase activity and mRNA with b-globin 30 UTR followed by
Reg1 target SL sequences (Figure 2K). Taken together, these re-
sults demonstrate that Reg1 and Roquin can recognize overlap-
ping target mRNAs via the same SLs present in their 30 UTRs.
Reg1 Localizes to the Endoplasmic Reticulum, but Not
PBs or SGs
The fact that Reg1 and Roquin recognize the same SL prompted
us to investigate their relationship further. We first examined the
involvement of deadenylation and decapping in Reg1-mediated
mRNA decay by overexpressing dominant-negative mutants of
Caf1 (Caf1-AA) and Dcp2 (Dcp2-AA). In contrast to Roquin-1
and -2, neither Caf1-AA nor Dcp2-AA affected Reg1-mediated
degradation of Il6 mRNA (Figure S4A).
We next investigated whether Reg1 and Roquin function in the
same subcellular location. Immunofluorescence staining re-
vealed that Roquin-1 localizes in PBs in NIH 3T3 and HeLa cells
and in SGs upon arsenite treatment (Figures S4B and S4C). In
contrast, NIH 3T3 cells expressing Flag-Reg1 did not localizeFigure 3. Reg1 Localizes to ER and Polysome Fraction
(A and B) NIH 3T3 cells expressing Flag-Reg1 were treated with arsenite and an
(C) Immunoelectron microscopy showing the localization of Reg1 in NIH 3T3 cell
mt, mitochondria.
(D) Subcellular fractions of Reg1 prepared from NIH 3T3 cells were analyzed by
(E) The lysates from HeLa cells were fractionated by sucrose gradient. The expre
(F–H) Quantification of RNAs of non-polysome and polysome fractions. The lysat
were fractionated by sucrose gradient (F), and RNAs from the fractions were ana
mean ± SD (n = 3).
See also Figure S4.
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In contrast, Reg1 co-localized with Calnexin, a type I membrane
protein of the endoplasmic reticulum (ER), but not with disulfide
isomerase (PDI), a protein found within the ER (Figures 3B and
S4E), indicating that Reg1 localizes on the surface of the ER.
Because the surface of the rough ER (RER) is studded with ribo-
somes, we next demonstrated that Reg1 also co-localizes to the
ribosome (Figures 3B and S4E). Moreover, immunoelectron mi-
croscopy analysis revealed that Reg1 localized to the cytoplasm
and the surface of the ER (Figure 3C). Furthermore, subcellular
fractionation of NIH 3T3 cells revealed that endogenous Reg1
was present in the cytosol and RER, but not smooth ER, which
does not contain ribosomes (Figure 3D).
To further investigate whether Reg1 localizes to translationally
active polysomes, HeLa cell lysates were subjected to polysome
fractionations (Figure 3E). Immunoblot analysis revealed that
endogenous Reg1 localized in polysomal fractions in addition
to non-polysome (non-ribosome and 40S-80S) fractions (Fig-
ure 3E), though Roquin-1 and -2 were localized in the non-poly-
some fractions.
Reg1, but Not Roquin, Regulates Target mRNAs in the
Polysomal Fraction
Next, we extracted RNAs from ribosomal fractions in HeLa cells
following Reg1 and Roquin-1/-2 siRNA treatment with or without
IL-1b stimulation and examined the levels of mRNA expression in
each fraction (Figures 3F and 3G). Reg1 and Roquin-1/-2 were
efficiently suppressed at the mRNA and protein levels (Figure 3G
and data not shown). Knockdown of Reg1 resulted in a large in-
crease in IL6 andPTGS2mRNAexpression in the polysome frac-
tions (fractions 7–12) compared with control cells, whereas the
mRNA in non-polysome fractions (fractions 3–6) were compara-
ble (Figure 3H). However, TNF and NFKBIA expression was un-
changed in Reg1 knockdown. In contrast, TNF and PTGS2
increased in Roquin-1/-2 knockdown cells. Interestingly, the in-
crease was observed in non-polysome fractions, but not in poly-
some fractions (Figure 3H).
We further detected PTGS2 in HeLa cells by using in situ hy-
bridization following IL-1b stimulation (Figure S4F). Knockdown
of Reg1 and Roquin-1/2 resulted in an increase in PTGS2
expression (Figures S4F and S4G). Whereas Reg1 knockdown
decreased PTGS2 localized in the PB, Roquin-1/-2 knockdown
increased PTGS2 localized in PBs (Figures S4F and S4H). Taken
together, these results demonstrate that Reg1 is critical for
controlling the expression of translationally active mRNAs,
whereas Roquin-1/2 regulate translationally inactive mRNAs in
PBs/SGs.alyzed by confocal fluorescence microscopy.
s. The black arrows indicate Reg1 localized at surface of ER. Scale bar, 1 mm.
immunoblotting.
ssion of Reg1 and Roquin in the fractions was analyzed by immunoblotting.
es from HeLa cells transfected with indicated siRNA and stimulated with IL-1b








Figure 4. Translationally Active mRNAs Are Targeted by Reg1 via the Stop Codon
(A) WT and Reg1–/– macrophages were labeled with EU, stimulated with LPS, and treated with anisomycin or CHX for 2 hr. EU-labeled Il6 and Ptgs2mRNAs were
captured by the Click-iT Nascent RNA Capture Kit and measured by RT-qPCR.
(legend continued on next page)
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Reg1 Destabilizes Translationally Active mRNA via Stop
Codons
We next treated Reg1–/– macrophages with protein translation
inhibitors, anisomycin, and cycloheximide (CHX) and examined
the kinetics of Il6 and Ptgs2mRNA degradation after stimulation
with LPS. Whereas Il6 and Ptgs2 mRNAs were stabilized in
Reg1–/– macrophages compared with WT, the difference was
lost following treatment with anisomycin or CHX (Figure 4A).
Reciprocally, destabilization of Il6mRNA induced by Reg1 over-
expression was no longer observed in response to treatment
with these protein synthesis inhibitors (Figures 4B and 4C). The
translation inhibitors did not alter Reg1 cellular localization or
its protein expression levels (Figures S5A and S5B).
We next examined the effect of Reg1 on translationally inactive
mRNA.We inserted a highly stable SL (SSL), whichwas shown to
inhibit translation (Doma and Parker, 2006), immediately up-
stream of the start codon of luciferase or Il6 (Figure 4D). Insertion
of the SSL to the luciferase reporter resulted in severe decrease
in luciferase activity, but not in itsmRNA, suggesting that the SSL
suppressed protein synthesis (Figure 4E). Overexpression of
Reg1 no longer destabilized Il6 with the SSL in the 50 UTR (Fig-
ures 4F and 4G), further confirming that active translation is
essential for Reg1-mediated mRNA decay.
However, Reg1-mediated mRNA destabilization was not
affected by the presence of IRES at the 50 UTR (Figures S5C
and S5D), suggesting that translation initiation is dispensable
for the function of Reg1. In contrast, Reg1 failed to destabilize
an Il6 whose stop codons were mutated throughout the 30 UTR
(Il6 mRNA-DSTOP) and luciferase Il6 30 UTR without a stop
codon (Figures 4F–4H). Requirement of stop codons in the
Reg1-mediated mRNA decay prompted us to hypothesize that
the distance between the stop codon and the Il6 mRNA SL is
important for Reg1-mediated destabilization. To examine this,
we prepared Il6 constructs harboring different distances be-
tween the stop codon and the SL (Figure 4I). Reg1 destabilized
Il6 mRNA with its original 30 UTR with (1–125), but not without
(1–81), a SL (Figure 4J). Although the construct harboring the
SL 23 bases downstream of the stop codon (64–125) was still
suppressed by Reg1, those with the SL immediately down-
stream of the stop codon (82–125) were not (Figure 4J). These
data suggest that the stop codon and SL structure require a
minimal distance (about >20 nt) to be suppressed by Reg1.
Reg1 Associates with Ribosome Proteins and UPF1
Next, we explored Reg1-associated proteins with a global prote-
omics approach using iTRAQ (Figure 5A). Levels of many ribo-
somal proteins in Reg1 immunoprecipitates from HeLa and
RAW cells expressing Flag-Reg1 increased compared to control(B and C) Tef-off 293 cells were co-transfected with pTRE-Il6 CDS-30 UTR and in
RNAs were prepared after Dox treatment, Il6 mRNA levels were determined by N
(D) Schematic representation of SSL-inserted mRNAs.
(E) The SSL inhibited luciferase activity, but not its mRNA expression.
(F and G) Degradation of Il6, SSL-inserted Il6, and stop-codon-deleted (DSTO
quantified (G).
(H) Luciferase activity of HeLa cells transfected with the Il6 reporter lacking a sto
(I and J) Schematic representation of deletion mutants of Il6 30UTR (I). Degradati
Unless otherwise indicated, data are mean ± SD (n = 3). See also Figure S5.
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precipitated by ultracentrifugation when incubated with highly-
purified ribosome in vitro (Figure 5C), suggesting that Reg1 is
physically associated with the ribosome.
In addition to ribosomal proteins, we found that Flag-Reg1 co-
precipitated UPF1 irrespective of Benzonase treatment (Figures
5B and 5D), suggesting that Reg1 and UPF1 exhibit direct pro-
tein-protein interaction. Whereas Reg1 lacking the N-terminal
helical domain (90–596) (Figure 5E) was able to bind UPF1 (Fig-
ure 5F), Reg1, including the RNase domain to the C-terminal end
(130–596) or only the C-terminal region (331–596), failed to co-
precipitate UPF1 (Figure 5F). In contrast, Reg1 lacking the linker
region between the N-terminal helical domain and the RNase
domain (D90–130) showed severely impaired interaction with
UPF1 (Figure 5F). Furthermore, overexpression of Reg1 (D90–
130) lost the competency to suppress Il6 and Ptgs2 30 UTR (Fig-
ure 5G), suggesting that the interaction between Reg1 and UPF1
is essential for Reg1 function.
UPF1 Is Critical for Reg1-Mediated mRNA Decay via Its
Helicase Activity
Next, we examined whether UPF1 is required for Reg1-mediated
decay. When we knocked down UPF1 in HEK293 cells, overex-
pressed Reg1 failed to degrade Il6 (Figures 6A and 6B). Further-
more, Reg1 overexpression no longer suppressed the luciferase
reporter constructs harboring 30 UTRs for IL6, PTGS2, ICOS, and
TNF-CDE37 in HeLa and RAW264.7 cells (Figures 6C, and S6A,
and S6B). In contrast, knockdown of UPF2 and UPF3x did not
affect Reg1-mediated suppression (Figures 6C and S6B).
Further, the response to Roquin overexpression was not in-
hibited by the loss of UPF1 (Figures 6D and S6C), indicating
that Reg1 and Roquin degrade target mRNA in UPF1-dependent
and -independent manners, respectively. Interestingly, knock-
down of UPF1 or Reg1 in HeLa and RAW264.1 cells resulted in
increased expression of IL6 and PTGS2, but not NFKBIA, in
response to IL-1b or LPS stimulation, respectively (Figures 6E
and S6D). Knockdown of UPF1, but not Reg1, resulted in an in-
crease in NMD-target genes such as SMG5 and GAS5 (Figures
6E and S6D).
Whereas overexpressed Reg1 co-precipitated Il6, UPF1
knockdown increased the amounts of Il6 co-precipitated with
Reg1 (Figure 6F). Knockdown of UPF1 abrogated Reg1-medi-
ated inhibition, even when we tethered Reg1 to the target
mRNA (Figures S6E and 6G), indicating that UPF1 is required
for Reg1 to cleave its target mRNAs after binding. Furthermore,
anisomycin treatment abrogated the lN-Reg1-mediated sup-
pression of Il6-5XBoxB expression (Figure 6H) without inhibiting
the Reg1-Il6 interaction (Figure S6F), indicating that translation isdicated expression plasmids. Cells were then treated with anisomycin or CHX,
orthern blot analysis (B), and the autoradiographs were quantified (C).
P) Il6 by Reg1 was measured as in (B) (F), and the autoradiographs were
p codon and Reg1 expression plasmids.





Figure 5. Reg1 Interacts with Ribosome Proteins and UPF1
(A) Schematic representation of the iTRAQ workflow.
(B) Proteins enriched by iTRAQ-based proteomics identifying Reg1-associated proteins.
(C) Recombinant Reg1 co-precipitated with ribosome purified from HeLa cells was analyzed by SDS-PAGE.
(legend continued on next page)
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required for Reg1 to degrade associatedmRNAs. The interaction
between Reg1 and UPF1was inhibited by the treatment with ani-
somycin (Figure 6I), suggesting that the association between
Reg1 and UPF1 is mediated by translation.
We next examined the role of UPF1 helicase activity in control-
ling Reg1. We depleted endogenous UPF1 with siRNA and re-
constituted it with exogenous siRNA-resistant WT and helicase
inactive (D648A/E649A; DEAA) (Franks et al., 2010) mutant
UPF1 in HeLa cells (Figure 6J). WT, but not the DEAA, rescued
Reg1-mediated suppression of Il6 30 UTR (Figure 6K). Further-
more, IL-1b-mediated expression of IL6 and PTGS2 was sup-
pressed by the UPF1 reconstitution in a manner dependent on
the helicase activity (Figure 6L). Nevertheless, the UPF1 DEAA
was capable of interacting with Reg1 (Figure S6G), indicating
that the UPF1 helicase activity is required for Reg1 at the degra-
dation step of its target mRNAs. Collectively, these results
demonstrate that UPF1 interacts with Reg1 upon translation
and is essential for Reg1-mediated degradation of target mRNAs
after recognition by acting as an RNA helicase.
Cooperative and Distinct Roles of Reg1 and Roquin in
Inflammatory Gene Expression
Because Reg1 and Roquin suppress common target mRNAs via
distinct molecular mechanisms, we investigated their relation-
ship by expressing mutant Reg1 and Roquin in the same cells.
First, we observed that the Reg1 D141N localized in SGs in
addition to ER following arsenite treatment (Figure S7A). Inter-
estingly, the Reg1 D141Nmutant cancelled suppression of lucif-
erase reporter constructs harboring 30 UTRs for Il6 (86–102) and
Ptgs2 30 UTR by Roquin overexpression (Figure S7B). In
contrast, Roquin-NT, whose localization is consistent with WT
Roquin (data not shown), failed to alter Reg1-mediated suppres-
sion (Figure S7B). These results suggest that Reg1 and Roquin
affect the same SL and that the Reg1 D141N mutant stays on
the 30 UTR and thereby inhibits the action of Roquin.
We further examined the roles of Reg1 and Roquin by gener-
ating BMMs harboring Reg1–/– and Roquin-1San/San alleles. We
found that the expression of Il6 and Tnf upon LPS stimulation
was augmented in Reg1–/– and Roquin-1San/San BMM, respec-
tively (Figure 7A). Further, Ptgs2 mRNA increased in Reg1–/–
and Roquin-1San/San BMM. Because Il6, Tnf, and Ptgs2 mRNAs
present in polysomal fractions rapidly increased in response to
IL-1b stimulation in HeLa cells and then decreased at later time
points (Figures 3H and S7C), we hypothesized that the contribu-
tion of translation-dependent decay by Reg1 changes in the time
course of BMM activation. Indeed, the difference in Il6 and Ptgs2
expression between WT and Reg1–/– BMM was more obvious 1
or 2 hr after LPS stimulation than 8 hr post-stimulation (Fig-
ure 7A). In contrast, the difference in Tnf and Ptgs2 expression
in WT and Roquin-1San/San BMM was greater 4 and 8 hr after
LPS than at earlier time points. These data demonstrate that
Reg1 and Roquin play more important roles earlier and later,
respectively, in response to TLR stimulation. Consistent with(D and F) Immunoblot analysis of UPF1 co-precipitated with Flag-Reg1-WT and
(E) Schematic representation of Reg1.
(G) Luciferase activity of HeLa cells transfected with indicated reporter and Reg1
See also Table S5.
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pressed more abundantly in Reg1–/– BMM 2 hr after LPS stimu-
lation compared with WT (Figure 7B). In contrast, the expression
of Ptgs2 protein in Roquin-1San/San BMM increased greatly 8 hr
after stimulation. Furthermore, the Ptgs2 protein/mRNA ratio
was higher in Reg1–/– BMM compared with WT and Roquin-
1San/San cells (Figure 7C). These results are consistent with the
increased expression of Ptgs2 mRNAs in polysomal fractions
in HeLa cells with defective expression of Reg1 (Figure 3H).
Although Reg1–/–; Roquin-1San/San double-mutant mice were
mostly embryonic lethal (data not shown), we successfully es-
tablished MEFs with the Reg1–/–; RoquinSan/San genotype. In
response to LPS and TNF stimulation in WT MEFs, the expres-
sion of genes, including Il6, Tnf, andPtgs2, was upregulated (Fig-
ures 7D and S7D). MEFs lacking Reg1 showed increased
expression of Il6 and Ptgs2 compared with WT, particularly in
the early phase of the responses (Figure 7D). Similarly, the
Roquin San mutation resulted in an increase in the expression
of Tnf, Il6, and Ptgs2 at later time points after LPS stimulation
(Figure 7D). Interestingly, Reg1–/–; RoquinSan/San MEFs showed
high increases in the expression of Il6, Tnf, and Ptgs2 mRNAs
both in early and late phases, suggesting that Reg1 and Roquin
in part redundantly regulate their target mRNAs, although Nfkbia
expression was not altered (Figures 7D and S7D).
Finally, we examined the genome-wide changes in gene
expression in WT, Reg1–/–, Roquin-1San/San, and Reg1–/–;
Roquin-1San/San MEFs with or without LPS stimulation by tran-
scriptome analysis (Table S6). A set of genes was greatly
increased in Reg1–/–; Roquin-1San/San double-mutant MEFs
compared with WT (Figure S7E). GSEA revealed that the mouse
counterparts of Reg1- and Roquin-binding mRNAs identified by
RIP-seq analysis were significantly enriched in genes more
abundantly expressed in Reg1–/–; Roquin-1San/San, Reg1–/–,
and Roquin-1San/San MEFs (Figures 7E, 7F, and S7F). These re-
sults indicate that the Reg1- and Roquin-binding mRNAs are
commonly regulated by these RNA binding proteins.
DISCUSSION
In this study, we found that Reg1 and Roquin target overlapping
mRNAs and SLs for degradation. Nevertheless, they degrade the
target mRNAs using different molecular mechanisms and in
different cellular locations. Whereas Roquin localizes in PBs/
SGs and degrades mRNAs via deadenylation like other mRNA
decay pathways, Reg1 associates with ribosomes and degrades
mRNAs in a translation-dependent manner (Figure 7G).
The UAU loop sequence was enriched in Reg1-binding sites,
and the loop sequence was important for Reg1-mediated
mRNA decay. So far, all validated Reg1 target SLs contain a
Py-Pu-Py loop sequence, andmutation of this loop sequence re-
sults in Reg1 unresponsiveness, a rule shared by Roquin target
mRNAs. We did not find a specific rule in the stem sequence
of Reg1-target mRNAs, although Roquin target stem sequencesD141N (D) or its deletion mutants (F) in HeLa cells.










Figure 6. UPF1 Is Essential for Reg1-Mediated mRNA Decay
(A and B) Reg1-mediated degradation of Il6 was measured in UPF1 knockdown cells (A), and the autoradiographs were quantified (B).
(C) Luciferase activity of HeLa cells transfected with UPF1, UPF2, or UPF3x siRNA, indicated reporter, and Reg1 expression plasmids.
(legend continued on next page)
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were reported to harbor the UUG sequence in their upper stem.
One possibility is that Reg1 can recognize a broader range of SL
structures than Roquin. However, crystal structures studies re-
vealed that Roquin ROQ domain interacts with the TNF-CDE
stem and a triloop with Py-Pu-Py sequences and that Roquin
uses mainly non-sequence-specific contacts with the RNA
(Schlundt et al., 2014; Schuetz et al., 2014; Tan et al., 2014).
Indeed, we found that overexpression of Roquin could affect 30
UTRs harboring a stem without the UUC sequence. Therefore,
the requirement for particular stem sequences may not be so
strict, and SL structures harboring a Py-Pu-Py loop sequence
might be more broadly recognized by both Reg1 and Roquin.
Reg1 and Roquin negatively regulate activation of T cells in
addition to the control of inflammatory gene expression in innate
immune cells (Pratama et al., 2013; Uehata et al., 2013; Vogel
et al., 2013). Icos is a common target of Reg1 and Roquin pro-
teins, and we found that a SL structure present in its 30 UTR is
recognized by both Reg1 and Roquin. A recent report showed
that Nfkbiz and Nfkbid are suppressed by Reg1 and Roquin in
T cells, controlling Th17 differentiation, although their relation-
ship was not studied (Jeltsch et al., 2014). We focused on the
mechanisms in innate immune and non-immune cells in this
study; however, it is likely that Reg1 and Roquin similarly regu-
late mRNAs related to T cell activation in a manner dependent
on the state of translation. Because lethality upon mutation of
both Reg1 and Roquin prohibited analyzing their roles in adult
T cells, it would be interesting to analyze their functional roles
in T cells by using conditional alleles in the future.
We found that Reg1-mediated mRNA decay requires transla-
tion and translation termination 20 bases or more upstream of
the SL. Similar to NMD, the stop codonmight be required for pre-
venting the disruption of the SL by the ribosome. In addition, the
requirement of UPF1 demonstrates that the Reg1-mediated
decay mechanism is highly similar to that of the quality control
pathway, NMD. In the execution of NMD, endonucleolytic cleav-
age by SMG6, as well as exonucleolytic cleavage induced by the
complex ofSMG5-SMG7, contributes to thedegradation of aber-
rant mRNAs (Eberle et al., 2009; Loh et al., 2013). SMG6-cleaved
mRNA product can be further degraded in a manner dependent
on the exosome and XRN1 exonucleases. Because Reg1 serves
as an endonuclease like SMG6, a similar complete mRNA degra-
dation system might operate upon cleavage by Reg1.
An open question is why Reg1-mediated mRNA decay re-
quires active translation. Given that translation-inactive mRNAs
are not affected by the absence of Reg1, this mechanism may
be beneficial for maintaining a certain reserve of inflammation-
related mRNAs. If Reg1 were to arbitrarily degrade its target(D) Luciferase activity of UPF1 knockdown HeLa cells transfected with indicated
(E) HeLa cells were transfected with the indicated siRNA and stimulated with IL-
(F) Cells expressing Il6 were transfected with UPF1 siRNA and/or Flag-Reg1. Il6
(G) Tethering Reg1 did not destabilize the luciferase-5BoxB under knockdown
indicated reporter and expression plasmids.
(H) Degradation of Il6CDS-5BoxB mRNA under treatment with anisomycin was m
(I) Immunoblot analysis of UPF1 co-precipitated with Flag-Reg1 in HeLa cells un
(J–L) HeLa cells transfected with UPF1 siRNA were reconstituted with siRNA-res
reconstitution (J). Luciferase activity of reconstituted cells, after transfection of ind
reconstituted cells stimulated with IL-1b (L).
Unless otherwise indicated, data are mean ± SD (n = 3). See also Figure S6.
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mRNA levels might become very low, and additional energy
would be required for de novo transcription. Alternatively, this
mechanism may lead to the production of one protein per
mRNA to keep control of short half-lives of Reg1-target mRNAs.
In contrast, Roquin-mediated decay is involved in the constitu-
tive decay of mRNAs and can be important for the regulation
of the amounts of stored immune-related mRNAs. The presence
of different regulatory proteinsmakes posttranslational control of
inflammation more elaborate than previously realized.
Although UPF1 is essential for NMD, the molecular mecha-
nisms of how UPF1 is involved in NMD are still under debate.
In one model, UPF1 is recruited to the mRNP complex upon
translation termination, forming a SURF complex (Kurosaki and
Maquat, 2013), and the helicase activity of UPF1 is proposed
to be required for the disassembly of themRNP complex (Franks
et al., 2010). However, this model was challenged in reports
demonstrating that UPF1 is associated with mRNAs even before
translation (Hogg and Goff, 2010; Hurt et al., 2013; Zu¨nd et al.,
2013). The helicase activity of UPF1 is essential for Reg1-medi-
ated cleavage of target mRNAs, although this activity is dispens-
able for Reg1 to interact with its target mRNAs. Therefore, the
Reg1-UPF1 interaction is possibly induced in the course of
translation irrespective of UPF1 helicase activity, which may
potentiate the RNase activity of Reg1 by remodeling an mRNP
complex (Figure 7G).
Reg1-mediated decay is dependent onUPF1, but not onUPF2
and UPF3x. Whereas all three UPF members are required for
NMD, UPF2 and UPF3x are also dispensable for SMD and repli-
cation-dependent histone mRNA decay (Kaygun and Marzluff,
2005; Kim et al., 2005). Nevertheless, Staufen 1 and 2 are sen-
sors for recognizing dsRNA sequences (Park et al., 2013) but
do not have RNase activity. Staufen1 was dispensable for the
Reg1-mediated decay (data not shown), and Reg1-mediated
mRNA decay is highly unique in that Reg1 serves as both a
sensor for the SL and a degradation enzyme simultaneously.
Although loss of function of both Reg1 and Roquin-1/-2 re-
sulted in a large increase in the expression of Tnf, Il6, and
Ptgs2, dysfunction of Reg1 or Roquin alone seems to differen-
tially regulate Il6 and Tnf, respectively. Further, both Reg1 and
Roquin-1 suppressed Tnf and Il6 mRNA 30 UTRs upon overex-
pression; thus, it is currently difficult to explain why Tnf expres-
sion did not increase under Reg1 deficiency. Because Reg1 is
critical for the regulation of Tnf in the absence of Roquin, Roquin
may bind with the Tnf SL more strongly than Reg1 and thus
reduce the accessibility of Reg1 to Tnf mRNA. Furthermore, it
would not be surprising if the translation status dynamicallyreporter and the Roquin-1 expression plasmid.
1b. RNA expression profiles were analyzed by RT-qPCR.
co-precipitated with Reg1 were analyzed by RT-qPCR.
of UPF1. Luciferase activity of UPF1 knockdown HeLa cells transfected with
easured and quantified.
der treatment with anisomycin.
istant HA-UPF1-WTR or HA-UPF1-DEAAR. Immunoblot analysis for the UPF1







(legend on next page)
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changes in the course of the life of an mRNA. Further studies will
uncover themechanisms of dynamic cellular regulation of mRNA
translation status in relation to mRNA decay.
Collectively, this study clearly demonstrates that the posttran-
scriptional regulation of inflammation is controlled by Reg1 and
Roquin in spatiotemporally distinct manners. Given that excess
and prolonged production of cytokines leads to the onset of in-
flammatory diseases, prolonged stability of inflammatory cyto-
kine mRNAs can be considered aberrant and thus targeted by
the quality control system. Differential regulation of Reg1- and
Roquin-mediated mRNA degradation is thus necessary for the
elaborate control of inflammation.
EXPERIMENTAL PROCEDURES
Materials and experimental procedures are detailed in the Supplemental
Experimental Procedures.
RIP-Sequencing
HeLa expressing Flag-Reg1-D141N, Roquin-1, or an empty vector were stim-
ulated with human IL-1b (10 ng/ml) for 2 hr. RNA-protein complexes were
immunoprecipitated with anti-Flag antibody (F3165; Sigma) bound to protein
G magnetic beads, and RNAs were extracted from the beads. RNA library
was prepared using Small RNA Sample Prep kit v1.0 (Illumina, Inc.) and
sequenced on a HiSeq 2000 system (Illumina) also according to the manufac-
turer’s instructions. The resulting set of trimmed reads was then mapped
against the human genome (hg19; NCBI).
mRNA Decay Assay
For mRNA decay experiments with Tet-off system, doxycycline (1 mg/ml)
(Sigma) was added to the medium for the indicated time intervals before har-
vesting Tet-off 293 cells. Total RNA was isolated using Trizol (Invitrogen).
mRNA levels were determined either by Northern blot or by RT-qPCR analysis.
For determining RNA decay using the Click-iT Nascent RNA Capture Kit
(Invitrogen), peritoneal macrophages were labeled with EU (0.5 mM) and stim-
ulated with LPS (100 ng/ml) for 2 hr, and themediumwas replaced with growth
medium without EU for the indicated time intervals before harvesting EU-
labeled peritoneal macrophages. EU-labeled RNAs (EU-RNAs) were bio-
tinylated, and the biotinylated RNAs were purified with streptavidin magnetic
beads and analyzed with RT-qPCR.
Luciferase Assay
HeLa cells were transfected with luciferase reporter plasmid pGL3 containing
the 30 UTRof indicated genes, together with expression plasmid for Regnase-1
or empty (control) plasmid. After 24 hr of cultivation, cells were lysed, and lucif-
erase activity in lysates was determined with the Dual-Luciferase Reporter
Assay system (Promega). The gene encoding Renilla luciferase was trans-
fected simultaneously as an internal control.
Statistical Analysis
Data are presented as means ± SD. Statistical significance was calculated
with a Student’s t test. Significance was accepted at the level of p < 0.05 (*),
p < 0.01 (**), or p < 0.001 (***).Figure 7. Roles of Reg1 and Roquin in the Control of Inflammatory mR
(A–C) WT, Reg1–/–, and Roquinsan/san BMMs were stimulated with LPS. RNA expr
by immunoblotting (B). The protein/mRNA ratio of Ptgs2 is shown in (C).
(D) WT, Reg1–/–; Roquinsan/san, Reg1–/–, and Roquinsan/san MEFs were stimulated
(E) GSEA of overlap between Reg1 (left) or Roquin (right) target genes (RIP-seq ba
ES plot is shown with genes ranked according to their Reg1–/–; RoquinSan/San en
(F) GSEA of overlap between Reg1 (left) or Roquin (right) target genes (RIP-seq
shown with genes ranked according to their Reg1–/– enrichment p value.
(G) A proposed model of mRNA degradation by Reg1 and Roquin.
Unless otherwise indicated, data are mean ± SD (n = 3). See also Figure S7 and
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